Literature DB >> 8767505

[Treatment of lymphatic metastasis of squamous cell carcinoma of the penis: experience at the National Tumor Institute of Milan].

G Pizzocaro1, L Piva, N Nicolai.   

Abstract

Between 1964 and 1990 inclusive, 204 consecutive naive patients with penile cancer and 14 patients with recurrence in the inguinal nodes have been referred at INT, Milano. Nodal metastases occurred in 100% of category T3, T4 patients, in 82% T2, in 60% G2-3 T1 and only in 16.5% of G1 T1. Out of the 47 patients who had primary ileoinguinal lymphadenectomy, 16 (34%) had negative nodes, versus 100% metastases in the 25 patients operated during the follow-up. The relapse rate was 45% in the 31 patients treated only surgically in the 1964-77 period, versus 16% in the 25 cases submitted to adjuvant chemotherapy between 1978 and 1990. All 4 relapses in the adjuvant treatment group occurred in the 8 patients with bilateral metastases. Twenty-six patients had fixed inguinal nodes: the first 10 were treated with radiotherapy, with or without methotrexate or bleomycin, and the last 16 have been submitted to neoadjuvant chemotherapy. Only one patient of the first group could be operated and all 10 died of cancer within 3 years. On the contrary, 9 (56%) of the 16 patients treated with neoadjuvant chemotherapy could undergo subsequent surgery and 5 (31%) are alive disease free since over 5 years. Prophylactic lymphadenectomy may be indicated in all T2, T3, T4 patients and in indifferentiated T1 tumors. Adjuvant and neoadjuvant chemotherapy can improve the results of radical surgery, significantly.

Entities:  

Mesh:

Year:  1996        PMID: 8767505

Source DB:  PubMed          Journal:  Arch Ital Urol Androl        ISSN: 1124-3562


  9 in total

Review 1.  [The significance of inguinal lymphadenectomy in carcinoma of the penis].

Authors:  E Preis; G Jakse
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 2.  [Systemic therapy of penile cancer].

Authors:  E Preis; P Albers; G Jakse
Journal:  Urologe A       Date:  2006-05       Impact factor: 0.639

Review 3.  [Options in palliative therapy for penile cancer].

Authors:  E Preis; G Jakse
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

Review 4.  [Lymphadenectomy for penile cancer. Diagnostic and prognostic significance as well as therapeutic benefit].

Authors:  H Borchers; G Jakse
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

Review 5.  Current trends in the management of carcinoma penis--a review.

Authors:  Iqbal Singh; A Khaitan
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

Review 6.  [Value of targeted therapy for penile cancer].

Authors:  A Heidenreich; D Thüer; D Pfister
Journal:  Urologe A       Date:  2008-10       Impact factor: 0.639

7.  [Neoadjuvant and adjuvant chemotherapy in patients with advanced penile cancer].

Authors:  A Heidenreich; G Jakse
Journal:  Urologe A       Date:  2007-10       Impact factor: 0.639

Review 8.  Metastatic penile carcinoma - an update on the current diagnosis and treatment options.

Authors:  Dimitri Barski; Evangelos Georgas; Holger Gerullis; Thorsten Ecke
Journal:  Cent European J Urol       Date:  2014-06-23

9.  External validation of nomograms for predicting cancer-specific mortality in penile cancer patients treated with definitive surgery.

Authors:  Yao Zhu; Wei-Jie Gu; Ding-Wei Ye; Xu-Dong Yao; Shi-Lin Zhang; Bo Dai; Hai-Liang Zhang; Yi-Jun Shen
Journal:  Chin J Cancer       Date:  2014-02-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.